웨어러블 접착제 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the wearable adhesive market size is expected to grow from USD 5.80 billion in 2025 to USD 6.39 billion in 2026 and is forecast to reach USD 10.37 billion by 2031 at 10.18% CAGR over 2026-2031.

This report is Segmented by Adhesive Chemistry (Silicone, Acrylic, Hydrogel, Hydrocolloid, and Others), Product Type (Diagnostic / Monitoring Patches, Therapeutic Patches, and More), Application (Healthcare, Sports and Fitness, Industrial and Military, and More), End-User (Hospitals, Clinics, Home-Care Settings, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Global Wearable Adhesive Market Trends and Insights

Growing Adoption of Wearable Medical and Fitness Devices

The FDA's March 2024 clearance of Dexcom Stelo, the first over-the-counter continuous glucose monitor, unlocked a new end-user pool of 25 million U.S. adults with Type 2 diabetes and in turn catalyzed adhesive-volume growth across retail channels. Venture funding signals similar momentum: Biolinq raised USD 58 million in April 2024 to scale precision multi-analyte biosensors that hinge on long-wear skin adhesives. Longer sensor life is now feasible; Dexcom's G7 platform reaches 15.5 days of reliable adhesion, reducing replacement frequency and widening consumer appeal. Each of these milestones expands the wearable adhesive market beyond clinical silos and embeds patches in everyday wellness management.

Advances in Skin-Friendly Adhesive Chemistries

Peer-reviewed data in Contact Dermatitis flagged isobornyl acrylate (IBOA) as an allergy trigger in certain CGM users, prompting industry-wide reformulations. Dymax answered with an IBOA-free and TPO-free 2000-MW series that still meets ISO 10993 requirements for skin contact. MIT researchers added a hydrogel barrier that averts fibrosis and allows months-long implantation without immune rejection. Such breakthroughs widen the wearable adhesive market by easing regulatory hurdles tied to adverse skin events.

Skin Irritation and Sensitivity Leading to Product Recalls

The FDA's MAUDE database lists rising dermatitis complaints against adhesive-based wearables; iRhythm's Zio Monitor and Abbott's FreeStyle Libre 3 both faced warnings or recalls tied to chemical burns or inaccurate readings. Pediatric burn cases triggered a Megadyne electrode correction, showing that one-formula-fits-all designs fall short of vulnerable-skin needs. These events temporarily cap the wearable adhesive market size, spark reformulation costs, and fuel a regulatory climate that favors proactive biocompatibility proof.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Home-Based Remote Patient Monitoring Programs
2. Industrial and Defense Uptake of Biometric Patches
3. Long-Wear Adhesion Versus Painless Removal Trade-Off

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Silicone held 35.78% of the wearable adhesive market in 2025 owing to hypoallergenic profiles, repositionability, and proven ISO 10993 records. NuSil and Elkem locked in health-care contracts by optimizing viscosity ranges for roll-to-roll coating lines. Hydrogel chemistries, although only 23.8% today, accelerate at an 11.02% CAGR as they wick perspiration and maintain electrical contact over long new work shifts. The wearable adhesive market size for hydrogel patches will likely surpass USD 3.18 billion before 2031 if current momentum persists. Hybrid siloxane-hydrogel matrices emerge as a middle path, especially for flexible printed-circuit assemblies that need both breathability and conductivity.

Second-order innovation targets conductivity and self-healing. Frontiers in Chemistry documented polyvinyl-alcohol hydrogels that restore bond integrity after mechanical damage and allow real-time ECG capture. Recyclable lipoic-acid adhesives from UC Berkeley extend sustainability narratives and could cut medical waste once performance data mature. Such green attributes may soon influence procurement scores, nudging the wearable adhesive market toward circular models.

Continuous glucose monitors, ECG patches, and fertility trackers established a 40.85% foothold, anchoring diagnostic leadership within the wearable adhesive market. The sector standard for adhesion rose in April 2025 when Dexcom's G7 extension hit a 15-day wear record. Yet therapeutic patches sprint faster at a 11.46% CAGR, powered by microneedle drug-delivery arrays that bypass first-pass metabolism. The wearable adhesive market size for this sub-class already exceeds USD 842.6 million and enjoys premium pricing because adhesion performance doubles as a drug-delivery safety metric.

Transdermal neuromodulation and pain-management devices reinforce the trend; their need for consistent skin impedance makes adhesive selection a critical clinical parameter. FDA guidance issued in 2024 specifically calls out 72-hour post-application peel tests for drug-in-adhesive systems, raising technical barriers for newcomers. Smart wound dressings fuse both product worlds by integrating moisture sensors with antimicrobial release, offering a long runway for differentiation.

Complete Report Scope:

• By Adhesive Chemistry
  • Silicone
  • Acrylic
  • Hydrogel
  • Hydrocolloid
  • Others
• By Product Type
  • Diagnostic / Monitoring Patches
    • Continuous Glucose Monitor (CGM)
    • ECG / Cardiac Patch
    • Temperature Patch
  • Therapeutic Patches
    • Microneedle Drug-delivery
    • TENS / Neuromodulation Patch
    • Transdermal Drug-in-Adhesive Patch
  • Wound-care Dressings
    • Advanced Hydrocolloid
    • Antimicrobial Foam
  • Smart Bandages
• By Application
  • Healthcare
  • Sports and Fitness
  • Industrial and Military
  • Consumer Wellness
• By End-user
  • Hospitals
  • Clinics
  • Home-care Settings
  • Ambulatory Surgical Centers
  • Other End-users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Turkey
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Nigeria
      • Rest of Africa

Geography Analysis

Regulatory clarity keeps North America on top with 37.22% share. The FDA's 2024 update on biological evaluation of medical devices gave early-mover benefits to suppliers already using IBOA-free chemistries. The region also hosts many of the clinical trials validating 10-day plus wear claims, embedding a virtuous cycle of data and reimbursement alignment.

Asia-Pacific logs the quickest 10.55% CAGR as China's Five-Year Plan funds domestic device innovation and local adhesive coating lines. India's new mandatory registration scheme, effective late-2023, filters sub-par imports and nudges reputable suppliers into joint ventures that expand the wearable adhesive market footprint.

Europe grows steadily, but its Green Deal pushes recyclability and solvents reduction, prompting R&D pivots toward water-based systems that may modestly lift unit costs.

1. 3M
2. Avery Dennison Medical
3. Nitto Denko Corporation
4. Scapa Healthcare (Mativ)
5. Henkel AG and Co. KGaA
6. Adhesives Research Inc.
7. DuPont (Liveo)
8. Rogers Corporation
9. Flexcon Company Inc.
10. Tapecon Inc.
11. Medtronic plc
12. Koninklijke Philips N.V.
13. MC10 Inc.
14. Vital Connect Inc.
15. Kenzen Inc.
16. Lief Therapeutics
17. Smith and Nephew plc
18. Coloplast A/S
19. Cardiac Insight Inc.
20. Integra LifeSciences Corp.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing adoption of wearable medical and fitness devices
  • 4.2.2 Advances in skin-friendly adhesive chemistries
  • 4.2.3 Expansion of home-based remote patient monitoring programs
  • 4.2.4 Industrial and defense uptake of biometric patches
  • 4.2.5 Regulatory push toward reusable devices requiring gentle adhesives
  • 4.2.6 Rise of minimally invasive drug-delivery microneedle patches
• 4.3 Market Restraints
  • 4.3.1 Skin irritation and sensitivity leading to product recalls
  • 4.3.2 Long-wear adhesion versus painless removal trade-off
  • 4.3.3 Environmental concerns over silicone/acrylate waste
  • 4.3.4 Fragile supply chain for medical-grade hydrogel polymers
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Porter's Five Forces Analysis
  • 4.6.1 Bargaining Power of Suppliers
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Threat of New Entrants
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Intensity of Competitive Rivalry
• 4.7 Investment Analysis
• 4.8 Assessment of the Impact of Macroeconomic Trends on the Market

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Adhesive Chemistry
  • 5.1.1 Silicone
  • 5.1.2 Acrylic
  • 5.1.3 Hydrogel
  • 5.1.4 Hydrocolloid
  • 5.1.5 Others
• 5.2 By Product Type
  • 5.2.1 Diagnostic / Monitoring Patches
    • 5.2.1.1 Continuous Glucose Monitor (CGM)
    • 5.2.1.2 ECG / Cardiac Patch
    • 5.2.1.3 Temperature Patch
  • 5.2.2 Therapeutic Patches
    • 5.2.2.1 Microneedle Drug-delivery
    • 5.2.2.2 TENS / Neuromodulation Patch
    • 5.2.2.3 Transdermal Drug-in-Adhesive Patch
  • 5.2.3 Wound-care Dressings
    • 5.2.3.1 Advanced Hydrocolloid
    • 5.2.3.2 Antimicrobial Foam
  • 5.2.4 Smart Bandages
• 5.3 By Application
  • 5.3.1 Healthcare
  • 5.3.2 Sports and Fitness
  • 5.3.3 Industrial and Military
  • 5.3.4 Consumer Wellness
• 5.4 By End-user
  • 5.4.1 Hospitals
  • 5.4.2 Clinics
  • 5.4.3 Home-care Settings
  • 5.4.4 Ambulatory Surgical Centers
  • 5.4.5 Other End-users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Middle East
      • 5.5.5.1.1 Saudi Arabia
      • 5.5.5.1.2 United Arab Emirates
      • 5.5.5.1.3 Turkey
      • 5.5.5.1.4 Rest of Middle East
    • 5.5.5.2 Africa
      • 5.5.5.2.1 South Africa
      • 5.5.5.2.2 Egypt
      • 5.5.5.2.3 Nigeria
      • 5.5.5.2.4 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 3M
  • 6.4.2 Avery Dennison Medical
  • 6.4.3 Nitto Denko Corporation
  • 6.4.4 Scapa Healthcare (Mativ)
  • 6.4.5 Henkel AG and Co. KGaA
  • 6.4.6 Adhesives Research Inc.
  • 6.4.7 DuPont (Liveo)
  • 6.4.8 Rogers Corporation
  • 6.4.9 Flexcon Company Inc.
  • 6.4.10 Tapecon Inc.
  • 6.4.11 Medtronic plc
  • 6.4.12 Koninklijke Philips N.V.
  • 6.4.13 MC10 Inc.
  • 6.4.14 Vital Connect Inc.
  • 6.4.15 Kenzen Inc.
  • 6.4.16 Lief Therapeutics
  • 6.4.17 Smith and Nephew plc
  • 6.4.18 Coloplast A/S
  • 6.4.19 Cardiac Insight Inc.
  • 6.4.20 Integra LifeSciences Corp.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-space and Unmet-need Assessment